Skip to main content
Equibles

FRANKLIN RESOURCES INC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 38777 San Mateo, CA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$286,155
+$234,307 QoQ
Shares Held
251,014
+572.9% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 170 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. AKBA ranks #29 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 340,275 $184,371,197
2 INDV
Indivior Pharmaceuticals, Inc.
 3,316,358 $136,070,166
3 NBIX
Neurocrine Biosciences Inc
 553,068 $93,214,076
4 VTRS
Viatris Inc
 5,658,439 $89,856,006
5 ZTS
Zoetis Inc.
 912,367 $65,562,688
6 ALKS
Alkermes plc.
 1,170,242 $61,320,679
7 AMLX
Amylyx Pharmaceuticals, Inc.
 2,950,225 $52,986,040
8 RDY
Dr Reddys Laboratories Ltd
 2,844,583 $41,218,006

All Filings in AKBA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $286,155 251,014
2026-03-31 $51,848 37,301
2025-12-31 $292,406 181,619
2025-09-30 $7,316,912 2,680,188
2025-06-30 $9,709,379 2,667,412
2025-03-31 $5,121,267 2,667,327
2024-12-31 $317,649 167,184
2024-09-30 $220,682 167,184
2023-12-31 $80,702 65,083
2023-09-30 $74,194 65,083
2023-06-30 $75,462 82,473
2023-03-31 $46,184 82,473
2022-12-31 $47,586 82,473
2022-09-30 $26,061 82,473
2022-06-30 $29,112 82,473
2022-03-31 $87,879 122,395
2021-12-31 $275,037 121,698
2021-09-30 $351,360 122,000